These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8503119

  • 1. Structural characterization of heparin's binding domain for human platelets.
    Suda Y, Marques D, Kermode JC, Kusumoto S, Sobel M.
    Thromb Res; 1993 Mar 15; 69(6):501-8. PubMed ID: 8503119
    [Abstract] [Full Text] [Related]

  • 2. Structural aspects of heparin responsible for interactions with von Willebrand factor.
    Poletti LF, Bird KE, Marques D, Harris RB, Suda Y, Sobel M.
    Arterioscler Thromb Vasc Biol; 1997 May 15; 17(5):925-31. PubMed ID: 9157957
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of heparin partial structures and their binding activities to platelets.
    Koshida S, Suda Y, Sobel M, Ormsby J, Kusumoto S.
    Bioorg Med Chem Lett; 1999 Nov 01; 9(21):3127-32. PubMed ID: 10560738
    [Abstract] [Full Text] [Related]

  • 4. Controllable production of low molecular weight heparins by combinations of heparinase I/II/III.
    Wu J, Zhang C, Mei X, Li Y, Xing XH.
    Carbohydr Polym; 2014 Jan 30; 101():484-92. PubMed ID: 24299802
    [Abstract] [Full Text] [Related]

  • 5. Specificity studies on the heparin lyases from Flavobacterium heparinum.
    Desai UR, Wang HM, Linhardt RJ.
    Biochemistry; 1993 Aug 17; 32(32):8140-5. PubMed ID: 8347612
    [Abstract] [Full Text] [Related]

  • 6. Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido-alpha-D-glucopyranose (1,4) 2-O-sulfo-alpha-L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages.
    Xiao Z, Zhao W, Yang B, Zhang Z, Guan H, Linhardt RJ.
    Glycobiology; 2011 Jan 17; 21(1):13-22. PubMed ID: 20729345
    [Abstract] [Full Text] [Related]

  • 7. Characterization of platelet binding of heparins and other glycosaminoglycans.
    Sobel M, Adelman B.
    Thromb Res; 1988 Jun 15; 50(6):815-26. PubMed ID: 3137688
    [Abstract] [Full Text] [Related]

  • 8. Examination of the substrate specificity of heparin and heparan sulfate lyases.
    Linhardt RJ, Turnbull JE, Wang HM, Loganathan D, Gallagher JT.
    Biochemistry; 1990 Mar 13; 29(10):2611-7. PubMed ID: 2334685
    [Abstract] [Full Text] [Related]

  • 9. Heavy metal binding to heparin disaccharides. I. Iduronic acid is the main binding site.
    Whitfield DM, Choay J, Sarkar B.
    Biopolymers; 1992 Jun 13; 32(6):585-96. PubMed ID: 1643264
    [Abstract] [Full Text] [Related]

  • 10. Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.
    Rhomberg AJ, Shriver Z, Biemann K, Sasisekharan R.
    Proc Natl Acad Sci U S A; 1998 Oct 13; 95(21):12232-7. PubMed ID: 9770469
    [Abstract] [Full Text] [Related]

  • 11. Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin.
    Rej RN, Ludwig-Baxter KG, Perlin AS.
    Carbohydr Res; 1991 Mar 20; 210():299-310. PubMed ID: 1878883
    [Abstract] [Full Text] [Related]

  • 12. Structural studies of the interaction of Crataeva tapia bark protein with heparin and other glycosaminoglycans.
    Zhang F, Walcott B, Zhou D, Gustchina A, Lasanajak Y, Smith DF, Ferreira RS, Correia MT, Paiva PM, Bovin NV, Wlodawer A, Oliva ML, Linhardt RJ.
    Biochemistry; 2013 Mar 26; 52(12):2148-56. PubMed ID: 23448527
    [Abstract] [Full Text] [Related]

  • 13. Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins.
    Moffat CF, McLean MW, Long WF, Williamson FB.
    Eur J Biochem; 1991 Dec 05; 202(2):531-41. PubMed ID: 1761054
    [Abstract] [Full Text] [Related]

  • 14. Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.
    Ernst S, Rhomberg AJ, Biemann K, Sasisekharan R.
    Proc Natl Acad Sci U S A; 1998 Apr 14; 95(8):4182-7. PubMed ID: 9539710
    [Abstract] [Full Text] [Related]

  • 15. Isolation and characterization of hexasaccharides derived from heparin. Analysis by HPLC and elucidation of structure by 1H NMR.
    Larnkjaer A, Hansen SH, Ostergaard PB.
    Carbohydr Res; 1995 Jan 03; 266(1):37-52. PubMed ID: 7697649
    [Abstract] [Full Text] [Related]

  • 16. Dynamic properties of biologically active synthetic heparin-like hexasaccharides.
    Angulo J, Hricovíni M, Gairi M, Guerrini M, de Paz JL, Ojeda R, Martín-Lomas M, Nieto PM.
    Glycobiology; 2005 Oct 03; 15(10):1008-15. PubMed ID: 15958415
    [Abstract] [Full Text] [Related]

  • 17. Cloning and Expression of Heparinase Gene from a Novel Strain Raoultella NX-TZ-3-15.
    Li Y, Lin Y, Jiang Y, Mehwish HM, Rajoka MSR, Zhao L.
    Appl Biochem Biotechnol; 2022 Oct 03; 194(10):4971-4984. PubMed ID: 35679015
    [Abstract] [Full Text] [Related]

  • 18. Structural studies on the tri- and tetrasaccharides isolated from porcine intestinal heparin and characterization of heparinase/heparitinases using them as substrates.
    Yamada S, Sakamoto K, Tsuda H, Yoshida K, Sugahara K, Khoo KH, Morris HR, Dell A.
    Glycobiology; 1994 Feb 03; 4(1):69-78. PubMed ID: 8186552
    [Abstract] [Full Text] [Related]

  • 19. Competitive inhibition of heparinase by persulfonated glycosaminoglycans: a tool to detect heparin contamination.
    Aich U, Shriver Z, Tharakaraman K, Raman R, Sasisekharan R.
    Anal Chem; 2011 Oct 15; 83(20):7815-22. PubMed ID: 21863856
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of low-density lipoprotein interaction with glycosaminoglycans.
    Gigli M, Ghiselli G, Torri G, Naggi A, Rizzo V.
    Biochim Biophys Acta; 1993 Apr 07; 1167(2):211-7. PubMed ID: 8466951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.